The pressure is ratcheting up on congress as an impeachment inquiry against President Trump continues.
Democrat Anthony Brindisi is one of the representatives under the microscope and hundreds of people wanting answers at a town hall in New Hartford.
Congressman Brindisi is one of eight representatives who have yet to say whether he supports the impeachment inquiry, and his response isn't satisfying everyone.
From both sides of the aisle, they’re focusing on one thing -- the impeachment inquiry against President Donald Trump.
"I want to find out if Anthony Brindisi is for impeachment of against impeachment,” said Syracuse Republican Committee Chairman Randy Potter. “It's time for him to stand up for what he believes other than being Mr. Waffle back and forth."
"I think it would ease the minds of people, especially those who are Democrats and those people that just want to know he backs finding out facts which I believe he does, but it would be better if he wasn't one of the eight," said Oxford resident Eileen Andrews.
"If there is a decision by leadership to put articles of impeachment on the floor, I will look at the evidence that's been presented, weigh all the facts and make a decision at that point," said Brindisi.
In the meantime, Brindisi believes the administration should cooperate.
"I think whatever can be done to get witnesses to come forward to have documents presented, that should be done so we can look at this,” said Brindisi. “It's a very serious matter."
This is why both democrats and republicans want to know Brindisi’s stance.
"I think it needs to be done to clear the president or move forward with what needs to done," said Andrews.
"He has to make a decision one way or another,” said Mohawk Valley/CNY For Trump Coordinator James Zecca. “If you're going to ask for the facts, then follow the procedure of law."
If the House votes on impeachment, a simple majority or 218 votes would be needed.
Representative Brindisi says he's not going to let the inquiry take away from other issues. He's focusing on getting laws passed before the end of the year on trade and prescription drug costs.